58 results
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
30 Aug 24
Current report (foreign)
9:46am
Nutrition’s leadership team brings unparalleled experience and expertise to the table. The company is led by CEO John Duffy, a seasoned executive … innovation in the consumer products space,” said David.
The leadership team is bolstered by the involvement of Kevin Harrington, a marketing icon known
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
is a sought after inspirational speaker across the United States and abroad, addressing diverse audiences on topics related to medicine, leadership … directors. The independent chair of the Audit Committee, Dr. Eric Hoskins, provides leadership for its independent directors. Mr. Durkacz, Mr. Saeed
424B5
QNTM
Quantum BioPharma Ltd
16 Feb 24
Prospectus supplement for primary offering
6:36pm
audiences on topics related to medicine, leadership, happiness, and living with purpose.
Our current Board of Directors consists of Zeeshan Saeed
6-K
EX-99.1
qkjcn3
7 Feb 24
FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates
4:03pm
6-K
EX-99.1
olhd8x
15 Dec 23
Material Change Report
9:46am
6-K
EX-99.1
gtzvboim2uvwa4qoy9xi
16 Nov 23
Material Change Report
10:51am
6-K
EX-99.1
lnh0d6u
5 Jul 23
FSD Pharma Inc. 6-K
6:00am
6-K
EX-99.1
mx7hkrs nx
30 Mar 23
Previously Headed Successful Global Expansion Resulting in Dramatic Increase in Sales and 35-Fold Increase in Shareholder Value for Drink Business
8:30am
6-K
EX-99.1
a8gdsa
28 Nov 22
FSD Pharma Inc. 6-K
9:08pm
6-K
EX-99.1
7c3ta9l89
31 May 22
FSD Pharma Inc. 6-K
8:30am
6-K
EX-99.1
msdd5e7x u6p
23 May 22
Annual General Meeting of the Shareholders
4:29pm
6-K
EX-99.1
swowx mwit1f
21 Apr 22
FSD Pharma Inc. 6-K
10:09am
20-F
1hs1jh
31 Mar 22
Annual report (foreign)
8:09am
6-K
EX-99.1
iol321jjshch2s7tnjtn
9 Dec 21
Regulatory Advisory Board will oversee the drug development pathway for FSD Pharma’s clinical drug candidates
8:00am
6-K
EX-99.1
iwffwf5o rmax
19 Oct 21
FSD Pharma Inc. 6-K
8:30am
6-K
EX-99.1
fbqxle00mh1zh5x8
27 Sep 21
Material Change Report
12:00am
6-K
EX-99.3
9q6l4h
21 Sep 21
THIS AGREEMENT made as of the 25th day of August, 2021
4:02pm